Author Question: A client is to receive darbepoetin alfa (Aranesp) adjunctive medication during chemotherapy. The ... (Read 346 times)

natalie2426

  • Hero Member
  • *****
  • Posts: 524
A client is to receive darbepoetin alfa (Aranesp) adjunctive medication during chemotherapy. The client says, Not another drug. Why do I need this one? How should the nurse respond?
 
  1. I know you are tired of drugs, but this is just one more.
  2. This drug will help you grow red blood cells.
  3. This drug will help keep you from getting infections.
  4. This is an erythropoiesis-stimulating factor.
  5. This drug will help you get more oxygen around to your tissues so you feel better.

Question 2

A client has been treated with an erythropoiesis-stimulating factor. Which client assessment would the nurse interpret as indicating the goal of this treatment has been reached?
 
  1. The client's hemoglobin values have risen.
  2. The client reports less shortness of breath on exertion.
  3. The client has not had an episode of epistaxis in over three weeks.
  4. The client reports enjoying a walk with family for the first time in months.
  5. The client has not had a fever since treatment began.



pikon

  • Sr. Member
  • ****
  • Posts: 361
Answer to Question 1

Correct Answer: 2,5
Rationale 1: This response does not answer the client's question.
Rationale 2: Darbepoetin alfa (Aranesp) is an erythropoiesis-stimulating factor.
Rationale 3: Darbepoetin alfa (Aranesp) does not increase immunity.
Rationale 4: The nurse should explain the medication in terms the client can understand.
Rationale 5: Darbepoetin alfa (Aranesp) stimulates production of red blood cells which carry oxygen. Getting additional oxygen to the tissues helps the client feel better.

Answer to Question 2

Correct Answer: 1,2,4
Rationale 1: The purpose of this therapy is to increase red blood cells which would increase hemoglobin.
Rationale 2: Since the client has more RBCs, more oxygen can be carried to tissues.
Rationale 3: This drug supports RBC production, not platelet production.
Rationale 4: Increase in activity level indicates treatment success.
Rationale 5: This treatment supports red blood cell production, not white blood cell production.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

Carbamazepine can interfere with the results of home pregnancy tests. If you are taking carbamazepine, do not try to test for pregnancy at home.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

Did you know?

Symptoms of kidney problems include a loss of appetite, back pain (which may be sudden and intense), chills, abdominal pain, fluid retention, nausea, the urge to urinate, vomiting, and fever.

Did you know?

Elderly adults are at greatest risk of stroke and myocardial infarction and have the most to gain from prophylaxis. Patients ages 60 to 80 years with blood pressures above 160/90 mm Hg should benefit from antihypertensive treatment.

For a complete list of videos, visit our video library